nav-left cat-right
cat-right

Protected: BIT’s 4th Annual Congress of Inte...

Conference Name: BIT’s 4th Annual Congress of International Drug Discovery Science & Technology 2006 (IDDST-2006) Date: May 25-Jun.2, 2006 Location: Dalian & Xi’an, China Theme: Combating Major Diseases for Happy Life Website: http://www.iddst.com Main Conference: Time: May 25-29, 2006 Venue: Dalian World Expo Center Satellite Meeting: Time: May 30-June 2, 2006 Venue: Conference Hall at Xi’an...

Iconix Pharmaceuticals Names New Head of Business ...

MOUNTAIN VIEW, Calif., Feb. 2 /PRNewswire/ — Iconix Pharmaceuticals, Inc., the leader in the expanding fields of toxico- and chemogenomics, today named Cate Sabatini to the position of executive vice president, Business Development. Ms Sabatini has extensive life science experience with an academic background in computer science and a career focus in the bioinformatics sector. At Iconix she will drive the commercial...

CytRx Announces Clinical and Corporate 2006 Milest...

LOS ANGELES, Jan. 11 /PRNewswire-FirstCall/ — CytRx Corporation (Nasdaq: CYTR) today announced projected major 2006 clinical and corporate milestones and reviewed 2005 achievements aimed to advance the Company’s goal to develop and commercialize human therapeutics, primarily in the area of small molecules and ribonucleic acid interference (RNAi). CytRx’s 2005 highlights include: * 1Q05 — ...

Honeycomb Connect Convention Don CeSar Beach Resor...

Over the last 12 months a select group of your peers have been enjoying the benefits associated with membership to the most cutting edge and high value, executive communities in existence today. Join us on January 29th – 31st at the Don CeSar Beach Resort in St. Pete Beach, Florida for our annual People In Life Sciences (P.I.L.S.) members meeting. Take part in in-depth discussions and hear from industry leaders as they...

Maxim Pharmaceuticals Receives Recommendation from...

Maxim Pharmaceuticals, Inc. (NASDAQ:MAXM)(SSE:MAXM)announced today that the Institutional Shareholder Services, or ISS,has recommended that Maxim’s stockholders vote in favor of theproposal to approve and adopt the merger agreement and the merger withEpiCept Corporation. ISS is a leading provider of proxy voting andcorporate governance services to institutional investors, analyzingproxies and issuing informed research...

Evotec Reaches First Milestone and Receives Succes...

HAMBURG, Germany, December 06, 2005 /PRNewswire-FirstCall/ — Evotec AG announced today that the first milestone has been achieved in its four-year drug discovery collaboration with Takeda Pharmaceutical Company Limited (Osaka, Japan, “Takeda”). Evotec has granted Takeda exclusive rights in a novel target in Alzheimer’s disease based on successful target identification and validation work triggering a...
Page 16 of 19« First...10...1415161718...Last »